Art
J-GLOBAL ID：200902210193493315   Reference number：08A0342328

生物学的製剤の使い分け

Author (2)：
YOSHIO NAOKO

About YOSHIO NAOKO

(大阪大 大学院生命機能研究科 免疫制御学)

About 大阪大 大学院生命機能研究科 免疫制御学

, 
NISHIMOTO NORIHIRO

About NISHIMOTO NORIHIRO

(大阪大 大学院生命機能研究科 免疫制御学)

About 大阪大 大学院生命機能研究科 免疫制御学


Material：
臨床リウマチ  (Clinical Rheumatology and Related Research)

About 臨床リウマチ


Volume： 20  Issue： 1  Page： 13-18  Publication year： Mar. 30, 2008 
JST Material Number： L0625A  ISSN： 0914-8760  Document type： Article
Article type： 文献レビュー  Country of issue： Japan (JPN)  Language： JAPANESE (JA)
Thesaurus term：
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
*biological preparation

About biological preparation

,...
Semi thesaurus term：
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
*rheumatoid arthritis

About rheumatoid arthritis

,...
Register(free) or Log In to access 

Please login to MyJ-GLOBAL to see full information. You also need to select "Display abstract, etc. of medical articles" in your MyJ-GLOBAL account page in order to see abstracts, etc. of medical articles.

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=08A0342328&from=J-GLOBAL&jstjournalNo=L0625A") }}
JST classification (1)：
JST classification
Category name(code) classified by JST.
Drug therapy(=pharmacotherapy)for musculoskeletal diseases 
(GG05020D)

About Drug therapy(=pharmacotherapy)for musculoskeletal diseases

Substance index (1)：
Substance index
Chemical Substance indexed to the Article.
Embrel

About Embrel

Reference (17)：
  • Buch, M. H., Bingham, S. J., Bejarano, V., et al.: Therapy of patients with rheumatoid arthritis: outcome of infliximab failures switched to etanercept.Arthritis Rheum., 57: 448-453, 2007.
  • Ehlers, S.: Tumor necrosis factor and its blockade in granulomatous infections: differential modes of action of infliximab ahd etanercept?Clin.Infect, Dis., 41, Suppl.3: S199-203, 2005.
  • Goekoop-Ruiterman, Y. P., de Vries-Bouwstra, J. K., Allaart, C. F., et al.: Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.Arthritis Rheum., 52: 3381-3390, 2005.
  • Hochberg, M. C., Lebwohl, M. G., Plevy, S. E., et al.: The benefit/risk profile ofTNF-blocking agents: findings of a consensus panel.Semin.Arthritis Rheum, 34: 819-836, 2005.
  • Keystone, E. C.: Switching tumor necrosis factor inhibitors: an opinion.Nature clinical practice, 2: 576-577, 2006.
ｍore...
Terms in the title (1)：
Terms in the title
Keywords automatically extracted from the title.
生物学的製剤

About 生物学的製剤


Return to Previous Page

TOP

BOTTOM